VOLASTRA THERAPEUTICS, INC.
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2019-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.volastratx.com
Clinical Trials
3
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
A Study of Sovilnesib in Subjects With Ovarian Cancer
- Conditions
- Chromosomal InstabilityHigh Grade Serous Adenocarcinoma of OvaryPrimary Peritoneal CarcinomaFallopian Tube Cancer
- Interventions
- First Posted Date
- 2023-10-16
- Last Posted Date
- 2025-10-20
- Lead Sponsor
- Volastra Therapeutics, Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT06084416
- Locations
- 🇺🇸
The University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
🇺🇸UCLA, Los Angeles, California, United States
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
- Conditions
- Advanced Solid TumorHigh Grade Serous Adenocarcinoma of OvarySquamous Non-small-cell Lung CancerTriple Negative Breast CancerHead and Neck Squamous Cell CarcinomaOvarian CarcinosarcomaUterine CarcinosarcomaUterine Serous CarcinomaEndometrium CancerChromosomal Instability
- Interventions
- First Posted Date
- 2023-06-15
- Last Posted Date
- 2025-10-22
- Lead Sponsor
- Volastra Therapeutics, Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT05902988
- Locations
- 🇺🇸
University of Southern California, Los Angeles, California, United States
🇺🇸University of Colorado Cancer Center, Aurora, Colorado, United States
🇺🇸Yale Cancer Center, New Haven, Connecticut, United States
Study of AMG 650 in Adult Participants With Advanced Solid Tumors
- First Posted Date
- 2020-03-03
- Last Posted Date
- 2023-08-24
- Lead Sponsor
- Volastra Therapeutics, Inc.
- Target Recruit Count
- 66
- Registration Number
- NCT04293094
- Locations
- 🇺🇸
The Angeles Clinic and Research Institute, West Los Angeles Office, Los Angeles, California, United States
🇺🇸Sarcoma Oncology Research Center LLC, Santa Monica, California, United States
🇺🇸Indiana University, Indianapolis, Indiana, United States